摘要:
Disclosed is a novel oxazolidinone derivative, particularly a novel oxazolidinone compound with a cyclic amidoxime or cyclic amidrazone group. Also disclosed is a pharmaceutical antibiotic composition including a novel oxazolidinone derivative, in vivo hydrolysable ester thereof, in vivo hydrolysable phosphate ester thereof, an isomer thereof or a pharmaceutically acceptable salt thereof as an effective ingredient. Because the novel oxazolidinone derivative, in vivo hydrolysable ester thereof, in vivo hydrolysable phosphate ester thereof, an isomer thereof or a pharmaceutically acceptable salt thereof exhibits a wide antibacterial spectrum against resistant bacteria, a low toxicity, and a strong antibacterial activity against Gram-positive and Gram-negative bacteria, it can be usefully used as an antibiotic.
摘要:
Disclosed is a novel oxazolidinone derivative, particularly a novel oxazolidinone compound with a cyclic amidoxime or cyclic amidrazone group. Also disclosed is a pharmaceutical antibiotic composition including a novel oxazolidinone derivative, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof or a pharmaceutically acceptable salt thereof as an effective ingredient. Because the novel oxazolidinone derivative, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof or a pharmaceutically acceptable salt thereof exhibits a wide antibacterial spectrum against resistant bacteria, a low toxicity, and a strong antibacterial activity against Gram-positive and Gram-negative bacteria, it can be usefully used as an antibiotic.
摘要:
The present invention relates to novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group, pharmaceutically acceptable salts thereof, methods for preparing the same and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group or the pharmaceutically acceptable salts thereof can be effectively used for the treatment of thromboembolism and tumor as an anticoagulant based on the inhibition of factor Xa.
摘要:
The present invention relates to novel oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof, and processes for preparing the same, and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof can be usefully employed as an anticoagulant for treating thromboembolism and tumors via inhibition of coagulation factor Xa.
摘要:
The present invention relates to novel oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof, and processes for preparing the same, and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof can be usefully employed as an anticoagulant for treating thromboembolism and tumors via inhibition of coagulation factor Xa.
摘要:
Disclosed are novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group, pharmaceutically acceptable salts thereof, methods for preparing the same and pharmaceutical compositions containing the same. The oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group or the pharmaceutically acceptable salts thereof can be effectively used for the treatment of thromboembolism and tumor as an anticoagulant based on the inhibition of factor Xa.
摘要:
The present invention relates to a composition comprising an extract of Dioscorea opposita having neuron-protective activity for preventing and treating brain disease. The extracts from Dioscorea opposita show potent neuronal cell protective activity by inhibiting neuronal cell death caused by neuro-toxicity of glutamate and H2O2 therefore it can be used as the therapeutics or health food for treating and preventing brain diseases.
摘要翻译:本发明涉及包含具有用于预防和治疗脑部疾病的神经元保护活性的薯Di皂甙提取物的组合物。 薯a皂苷提取物通过抑制由谷氨酸和H 2 O 2的神经毒性引起的神经元细胞死亡,显示出有效的神经元细胞保护活性,因此可用作治疗和预防脑疾病的治疗剂或保健食品。
摘要:
An image forming apparatus includes a frame that has a first side frame and a second side frame facing each other, a platen which is rotatably supported by the first side frame and the second side frame, a head to move in first or second directions to press against or separate from the platen, a head supporting member connected to the head to support the head, and an adjusting member to pivotally support opposite ends of the head supporting member, wherein one of the two ends is fixed to the first side frame, and the other of the two ends is movably coupled to the second side frame so as to be able to move relative to the fixed end in the first and second directions.
摘要:
The present invention relates to a composition comprising an extract of Dioscorea opposita having neuron-protective activity for preventing and treating brain disease. The extracts from Dioscorea opposita show potent neuronal cell protective activity by inhibiting neuronal cell death caused by neuro-toxicity of glutamate and H2O2 therefore it can be used as the therapeutics or health food for treating and preventing brain diseases.
摘要翻译:本发明涉及包含具有用于预防和治疗脑部疾病的神经元保护活性的薯Di皂甙提取物的组合物。 薯a皂苷提取物通过抑制由谷氨酸和H 2 O 2的神经毒性引起的神经元细胞死亡,显示出有效的神经元细胞保护活性,因此可用作治疗和预防脑疾病的治疗剂或保健食品。
摘要:
A stacked integrated circuit package-in-package system is provided forming a first integrated circuit package having a first peripheral contact, forming a second integrated circuit package having a second peripheral contact, stacking the second integrated circuit package on the first integrated circuit package in an offset configuration with the first peripheral contact exposed, the offset configuration provides a second package overhang with the second integrated circuit package above the first integrated circuit package, electrically connecting the first peripheral contact and a package substrate top contact, and electrically connecting the second peripheral contact and the package substrate top contact.